EMMA International Launches New Reshoring Services to Strengthen U.S. Life Sciences Manufacturing

EMMA International Reshoring Services for U.S. Life Sciences Manufacturing

EMMA International's new reshoring services empower life science companies to bring manufacturing back to the U.S. with regulatory expertise and operational speed.

A Comprehensive Solution for Returning Critical Operations to U.S. Soil

Reshoring isn’t just about logistics; it’s about long-term resilience. We’re proud to be the trusted partner for life science organizations reshoring with confidence, compliance, and speed.”
— Kira Jabri, COO, EMMA International
BIRMINGHAM, MI, UNITED STATES, July 29, 2025 /EINPresswire.com/ -- E.M.M.A. International Consulting Group, Inc. (EMMA International1), a leading global consulting firm specializing in regulatory compliance, quality systems, and operational excellence, proudly announces the launch of its new Reshoring Services2. This comprehensive offering is designed to support life science companies as they bring manufacturing operations back to the United States—strategically, efficiently, and compliantly.

In an era defined by global supply chain vulnerabilities, regulatory pressure, and geopolitical uncertainty, reshoring is becoming a strategic imperative. EMMA International is responding with a full-suite solution tailored specifically to the complex needs of pharmaceutical, biotech, medical device, and diagnostics companies.

“Reshoring isn’t just about logistics, it’s about long-term business resilience,” said Kira Jabri, COO of EMMA International. “We’re proud to be the trusted partner for life science organizations looking to reshore operations with confidence, compliance, and speed.”

The new Reshoring Services include:
• Strategic Planning & Feasibility Assessments
• Site Selection & Facility Readiness
• Regulatory Compliance & Quality Systems
• Engineering & Validation Support
• Workforce Scaling & Contingent Labor

Whether relocating overseas operations or expanding domestic capacity, EMMA International delivers the regulatory insight, quality leadership, and execution horsepower companies need to thrive in today’s complex landscape.

For additional information, please contact Kira Jabri, COO, at 248-987-4497 or email at kira.jabri@emmainternational.com.

Kira Jabri
EMMA International Consulting Group
248-987-4497
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
X

WATCH NOW: EMMA CASE STUDY: Reshoring Pharmaceutical Manufacturing at https://www.youtube.com/watch?v=L0X9izFqUg8

1 https://emmainternational.com/
2 https://emmainternational.com/reshoring/
3 http://emmainternational.com/life-sciences-and-ai-technology/

This press release can be viewed online at: https://www.einpresswire.com/article/834813688/

Disclaimer: If you have any questions regarding information in this press release please contact the company listed in the press release. Please do not contact EIN Presswire. We will be unable to assist you with your inquiry. EIN Presswire disclaims any content contained in these releases.

© 1995-2025 Newsmatics Inc. All Right Reserved.